Literature DB >> 12006426

Mortality after hospitalization for COPD.

Pedro Almagro1, Esther Calbo, Anna Ochoa de Echagüen, Bienvenido Barreiro, Salvador Quintana, José L Heredia, Javier Garau.   

Abstract

OBJECTIVES: To identify variables associated with mortality in patients admitted to the hospital for acute exacerbation of COPD.
DESIGN: Prospective cohort study.
SETTING: Acute-care hospital in Barcelona (Spain). PATIENTS: One hundred thirty-five consecutive patients hospitalized for acute exacerbation of COPD, between October 1996 and May 1997. MEASUREMENTS AND
RESULTS: Clinical, spirometric, and gasometric variables were evaluated at the time of inclusion in the study. Socioeconomic characteristics, comorbidity, dyspnea, functional status, depression, and quality of life were analyzed. Mortality at 180 days, 1 year, and 2 years was 13.4%, 22%, and 35.6%, respectively. Sixty-four patients (47.4%) were dead at the end of the study (median follow-up duration, 838 days). Greater mortality was observed in the bivariate analysis among the oldest patients (p < 0.0001), women (p < 0.01), and unmarried patients (p < 0.002). Hospital admission during the previous year (p < 0.001), functional dependence (Katz index) [p < 0.0004], greater comorbidity (Charlson index) [p < 0.0006], depression (Yesavage Scale) [p < 0.00001]), quality of life (St. George's Respiratory Questionnaire [SGRQ]) [p < 0.01], and PCO(2) at discharge (p < 0.03) were also among the significant predictors of mortality. In the multivariate analysis, the activity SGRQ subscale (p < 0.001; odds ratio [OR], 2.62; confidence interval [CI], 1.43 to 4.78), comorbidity (p < 0.005; OR, 2.2; CI, 1.26 to 3.84), depression (p < 0.004; OR, 3.6; CI, 1.5 to 8.65), hospital readmission (p < 0.03; OR, 1.85; CI, 1.26 to 3.84), and marital status (p < 0.0002; OR, 3.12; CI, 1.73 to 5.63) were independent predictors of mortality.
CONCLUSIONS: Quality of life, marital status, depressive symptoms, comorbidity, and prior hospital admission provide relevant information of prognosis in this group of COPD patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12006426     DOI: 10.1378/chest.121.5.1441

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  158 in total

1.  Comparison of clinico-physiologic and CT imaging risk factors for COPD exacerbation.

Authors:  Jung-Wan Yoo; Yoonki Hong; Joon Beom Seo; Eun Jin Chae; Seung Won Ra; Ji-Hyun Lee; Eun Kyung Kim; Seunghee Baek; Tae-Hyung Kim; Woo Jin Kim; Jin Hwa Lee; Sang-Min Lee; Sangyeub Lee; Seong Yong Lim; Tae Rim Shin; Ho Il Yoon; Seung Soo Sheen; Jae Seung Lee; Jin Won Huh; Yeon-Mok Oh; Sang-Do Lee
Journal:  J Korean Med Sci       Date:  2011-11-29       Impact factor: 2.153

2.  Factors associated with mortality in patients with exacerbation of chronic obstructive pulmonary disease hospitalized in General Medicine departments.

Authors:  Bernardino Roca; Pedro Almagro; Francisco López; Francisco J Cabrera; Lorena Montero; David Morchón; Jesús Díez; Fernando de la Iglesia; Mario Fernández; Jesús Castiella; Elena Zubillaga; Jesús Recio; Joan B Soriano
Journal:  Intern Emerg Med       Date:  2010-10-01       Impact factor: 3.397

3.  Functioning and psychological status among individuals with COPD.

Authors:  Patricia P Katz; Mark D Eisner; Edward H Yelin; Laura Trupin; Gillian Earnest; John Balmes; Paul D Blanc
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

4.  Managing chronic diseases: end of life is more than death.

Authors:  Patrick White
Journal:  BMJ       Date:  2005-04-23

5.  Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease.

Authors:  Michael Spencer; Andrew H Briggs; Ronald F Grossman; Laureen Rance
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

6.  GWAS and systems biology analysis of depressive symptoms among smokers from the COPDGene cohort.

Authors:  Jonathan T Heinzman; Karin F Hoth; Michael H Cho; Phuwanat Sakornsakolpat; Elizabeth A Regan; Barry J Make; Gregory L Kinney; Frederick S Wamboldt; Kristen E Holm; Nicholas Bormann; Julian Robles; Victor Kim; Anand S Iyer; Edwin K Silverman; James D Crapo; Shizhong Han; James B Potash; Gen Shinozaki
Journal:  J Affect Disord       Date:  2018-09-07       Impact factor: 4.839

Review 7.  Comorbidities in chronic obstructive pulmonary disease.

Authors:  Wissam M Chatila; Byron M Thomashow; Omar A Minai; Gerard J Criner; Barry J Make
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

8.  Symptom cluster, healthcare use and mortality in patients with severe chronic obstructive pulmonary disease.

Authors:  Soo Kyung Park; Janet L Larson
Journal:  J Clin Nurs       Date:  2014-01-27       Impact factor: 3.036

9.  Factors to inform clinicians about the end of life in severe chronic obstructive pulmonary disease.

Authors:  Roberto Benzo; Wendy Siemion; Paul Novotny; Alice Sternberg; Robert M Kaplan; Andrew Ries; Robert Wise; Fernando Martinez; James Utz; Frank Sciurba
Journal:  J Pain Symptom Manage       Date:  2013-03-21       Impact factor: 3.612

10.  Effects of depression diagnosis and antidepressant treatment on mortality in Medicare beneficiaries with chronic obstructive pulmonary disease.

Authors:  Jingjing Qian; Linda Simoni-Wastila; Patricia Langenberg; Gail B Rattinger; Ilene H Zuckerman; Susan Lehmann; Michael Terrin
Journal:  J Am Geriatr Soc       Date:  2013-04-25       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.